Case study · Blood purification therapy manufacturer · Intensive care · Therapy recommendation

In which patient, when and at what dose should the therapy be used?

Evidence-based therapy recommendations for extracorporeal blood purification.

3

Publications, peer-reviewed and open access

Dr. Peter Recknagel and an intensive care physician going through a checklist at the ward desk

Before

The therapy was in broad clinical use. But the literature lacked high-quality data on the criteria for selecting patients, when to start the therapy and how to dose it.

What we did

  • A chain of evidence in which each paper builds on the previous one
  • The establishment of a Dynamic Scoring System
  • Publications on patient selection and timing, on clinical effects such as fluid balance, and a consensus statement on best practice

Result

  • 3 peer-reviewed Open-access publications in a sequence that builds step by step
  • A basis for clinical discussions, congresses and the further development of the therapy
“Through a consistently cumulative scientific approach, supported by our long-standing scientific partner Dr. Recknagel, patient selection, timing and dosing could be addressed in a structured way and on a much more robust footing for the first time.”
Senior Director Medical, blood purification therapy manufacturer

Broad use alone does not convince a guideline committee. A series of publications that answers the open questions one after another lays the foundation for that.

Matching service:Publications through to PubMed

When do you have to start on evidence at the latest?

Answer 18 short questions about your product. You then receive your Evidence Plan as a PDF: which building blocks must be ready by your next deadline, when you have to start at the latest, and what budget to expect.

Create your Evidence Plan Takes 4 minutes, is confidential and free of charge.
Example of the Evidence Plan result: deadline, latest start, budget range and timeline of the building blocks

This is what your result looks like (example)

Which question is currently facing your product?

In the evidence call, you hear in 30 minutes how we would answer it.